|
USDA-HHS Birth to 24 Months & Pregnant Women Project Federal Expert Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NHLBI, NCI, NICHD, NIDDK, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP
|
The current work includes identifying topics of public health importance and conducting a small number of systematic reviews on diet and health for infants, toddlers, and women who are pregnant; it will not include specific dietary recommendations or advice. The scientific basis for dietary guidance for these population groups will be informed by the advisory report of the next (2020) Dietary Guidelines Advisory Committee.
|
|
Using Real-time Prescription and Insurance Claims Data to Support the HIV Care Continuum
|
Research Initiative
|
CDC
|
NIMH
|
The Centers for Disease Control (CDC) and the National Institute of Mental Health (NIMH) have established Memorandum of Understanding (MOU) and an Intra-Departmental Delegation of Authority (IDDA) co-funding agreement to collaboratively advance research under a cooperative agreement titled “Using Real-time Prescription and Insurance Claims Data to Support the HIV Care Continuum (CDC RFA-PS-19-003).” The purpose of the cooperative agreement is to develop, implement and evaluate a “Data-to-Care (D2C) Rx” and “Insurance-based D2C” model. Both models will use real-time pharmacy claims data to identify persons with HIV who fail to fill antiretroviral (ARV) medications and to target these individuals for escalating adherence, retention and re-linkage interventions. The D2C Rx model will start by identifying persons with HIV who fail to fill prescribed ARV medications while the Insurance-based D2C model will start with medical (diagnosis and procedure) claims to identify persons with diagnosed HIV and then use pharmacy claims data to determine whether these individuals fill ARV prescriptions.
|
|
Vaccine Research Center (VRC) - National Vaccine Program Office (NVPO) Collaboration
|
Other
|
CDC, FDA
|
NIAID
|
NVPO provided personnel in a Detail Assignment to support the following activities: 1. Guide and assist with National Institute of Allergy and Infectious Diseases (NIAID) Emerging Infectious Disease (EID) Outbreak Research Reponse; 2. Direct strategic planning and advance development for the VRC''s expanding portfolio of candidate vaccines and biotherapeutics; 3. Lead maternal immunization clinical research and vaccine safety surveying and monitoring for VRC''s EID Outbreak Research Response to the Zika virus epidemic, and other vaccine candidates being developed at the VRC; 4. Facilitate collaborative efforts with stakeholders, NIAID, Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), academic institutions, private organizations, and industries dedicated to expanding the state of knowledge of vaccine health globally, to enhance research and clinical readiness; 5. Facilitate advancement of a national strategy to develop medical products and strategies to counter emerging and re-emerging infectious diseases.
|
|
Vaccine Working Group (Filovirus)
|
Committee, Work group, Advisory group, or Task Force
|
FDA, OS
|
NIAID
|
This working group is collaborating on NHP control animal data and meta analysis. Collaboration includes exchange of study data, study reports, development of a NHP control database and statisical analysis plan and report. The objective is to provide a data package to the Food and Drug Administration (FDA) to support vaccine product development and licensure.
|
|
Value Set Authority Center (VSAC)
|
Resource Development
|
AHRQ, CDC, CMS, OS
|
NLM
|
The National Library of Medicine (NLM) provides an online repository of value sets (code sets from standardized medical vocabularies) that are used for clinical quality measurement in the CMS EHR Incentive Program (meaningful use). The Value Set Authority Center (VSAC) provides downloadable access to all official versions of vocabulary value sets contained in the 2014 Clinical Quality Measures (CQMs). Each value set consists of the numerical values (codes) and human-readable names (terms), drawn from standard vocabularies such as SNOMED CT ®, RxNorm, LOINC, and ICD-10-CM, which are used to define clinical concepts used in clinical quality measures (e.g., patients with diabetes, clinical visit).
|
|
Virology Interest Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NCI, NHLBI, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIMH, NINDS
|
The Virology Interest Group comprises researchers at National Institutes of Health (NIH) and in the local area who are interested in virology. The group organizes activities designed to promote interactions and exchange information.
|
|
Why has progress in hypertension control plateaued in the United States, and how can progress be restarted? Establishing a Research Agenda for the 2020’s
|
Meeting/ Workshop
|
CDC
|
NHLBI
|
Workshop to develop a research agenda for Centers for Disease Control and Prevention (CDC) and National Heart, Lung, and Blood Institute (NHLBI).
|
|
Work Group on Harmonizing Hemoglobinopathy Data Sets
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA
|
NLM, NCATS, NHLBI, NICHD, NIGMS, OD/OER
|
The mission of the Workgroup for Harmonizing Hemoglobinopathy Data Sets is to create a resource for federal programs and extramural communities to use in data systems that incorporate data elements in hemoglobinopathies. Specifically this entails establishing a Hemoglobinopathies Uniform Medical Language including: identifying specific goals and objectives for the kind of data that are required by these programs; case definitions for electronic data systems at all levels; consensus about conditions and data elements to be included; and differentiation between data needs for surveillance and for registries/biorepository.
|
|
Workshop on Metabolic Interactions between Folic Acid Excess and Vitamin B12 Deficiency
|
Meeting/ Workshop
|
FDA
|
NIDDK, NCI, NIA, NICHD, OD/DPCPSI/ODS
|
The main objectives of the workshop were to deliberate on the potential causal mechanisms of excess folate/folic acid and Vitamin B12 deficiency, as well as potential biological effects of unmetabolized folic acid. Another main objective was to develop consensus on various basic and clinical experimental study designs, intervention strategies and experimental models for exploring the biochemical mechanisms for these interactions. This workshop was held July 31 - Aug. 1, 2019.
|
|
World Cancer Research Day, HPVAware, and World No Tobacco Day, World Cancer Day observances
|
Public Education Campaign
|
OS
|
NCI, FIC
|
The National Cancer Institute (NCI) Office of Communications and Public Liaison and Center for Global Health collaborate with the Department of Health and Human Services (DHHS) Assistant Secretary for Public Affairs Digital Media Office to coordinate public education campaigns featuring digital materials that highlight prevention promotion and wellness programs. These materials are shared across all HHS Operating Divisions (OPDIVs).
|